Seiffge, D. J.
Polymeris, A. A.
Fladt, J.
Lyrer, P. A.
Engelter, S. T.
De Marchis, Gian Marco http://orcid.org/0000-0002-0342-9780
Article History
Received: 25 July 2018
Accepted: 13 September 2018
First Online: 6 October 2018
Compliance with ethical standards
:
: David J. Seiffge (MD): has received research support from the Swiss Heart Foundation, the Science Funds of the University Hospital Basel and the University of Basel and served on a scientific advisory board for Bayer and Pfizer. Alexandros Polymeris (MD): has received research support from the Swiss Academy of Medical Sciences/Bangerter Foundation. Joachim Fladt (MD): has received research support from the Swiss Heart Foundation. Philippe A. Lyrer (MD): has received honoraria from Bayer, Daiichi-Sankyo, Schering Pharma, Boehringer Ingelheim, and Shire plc; research support from AstraZeneca, Boehringer Ingelheim, Sanofi-aventis, PhotoThera, the Swiss National Science Foundation, and the Swiss Heart Foundation. Stefan T. Engelter (MD): has received honoraria from Bayer and Boehringer Ingelheim, has served on scientific advisory boards for Bayer, Boehringer Ingelheim, BMS/Pfizer, Covidien and on the editorial board of Stroke. He has received an educational grant from Pfizer and research support from the Science Funds (Wissenschaftsfonds) of the University Hospital Basel, the University Basel, the Swiss Heart Foundation, and the Swiss National Science Foundation. Gian Marco De Marchis (MD, M.Sc.): has received research support from the Swiss National Science Foundation, the Science Funds (Wissenschaftsfonds) of the University Hospital Basel and University of Basel, the Bangerter-Rhyner-Stiftung, the Swisslife Jubiläumsstiftung for Medical Research, the Swiss Neurological Society, the Fondazione Dr. Ettore Balli, as well as the De Quervain research grant and support from Thermo Fisher GmbH; moreover, he received travel honoraria by Bayer and speaker honoraria by Medtronic and BMS/Pfizer.